Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas

American Journal of Surgical Pathology

Volumn 20, Issue 2, 1996, Pages 202-210

  Tsang, William Y W ^a   Chan, John K C ^a   Ng, C S ^a   Pau, M Y ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

CD56; Immunohistochemistry; Lymphoma; Natural killer cell lymphoma; Neural cell adhesion molecule; T cell lymphoma

Indexed keywords

CD56 ANTIGEN; NERVE CELL ADHESION MOLECULE;

ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; T CELL LYMPHOMA; TUMOR LOCALIZATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD56; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KILLER CELLS, NATURAL; LYMPHOID TISSUE; LYMPHOMA, T-CELL; MALE; MICROTOMY; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PARAFFIN EMBEDDING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0030030389     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199602000-00009     Document Type: Article

References (45)

1. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993;17:392-9.
2. Carey JL, England BG. Leukocyte antigens and monoclonal reagents: production and characterization. In: Keren DF, ed. Flow cytometry and clinical diagnosis. Chicago: American Society Clinical Pathologists Press, 1989:41-138.
3. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/ nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987;11:418-29.
4. Chan JKC, Ng CS, Tsang WYW. Nasal/nasopharyngeal lymphomas: an immunohistochemical analysis of 57 cases on frozen tissues [Abstract]. Mod Pathol 1993;6:87A.
5. Chan JKC, Sin VC, Ng CS, Lau WH. Cutaneous relapse of nasal T-cell lymphoma clinically mimicking erythema multiforme. Pathology 1989;21:164-8.
6. Chan JKC, Tsang WYW, Wong KF. Classification of natural killer cell neoplasms [Letter]. Am J Surg Pathol 1994;18: 1177-8.
7. Chan JKC, Tsang WYW, Ng CS, Pau MY. Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. Hum Pathol 1995;26:1139-43.
8. Chan JKC, Yip TTC, Tsang WYW, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Palhol 1994;18:938-46.
9. Gelb AB, van de Rijn M, Regula DP, et al. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol 1994;25:953-60.
10. Gentile TC, Uner AH, Hutchison RE, et al. CD3+ CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 1994;84:2315-21.
11. Grogan TM, Guptil V, Mullen J, et al. Polysialated NCAM as a neurodeterminant in malignant lymphoma [Abst]. Mod Pathol 1994;7:110A.
12. Ho FCS, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphom of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 1990;21: 1041-50.
13. Ho FCS, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol Oncol 1990;8:271-81.
14. Imamura N, Kusunoki Y, Kawaha K, et al. Aggressive natural killer cell leukemia/lymphoma: report of four cases and review of the literature. Br J Hematol 1990;75:49-59.
15. Jaffe ES. Post-thymic cell lymphomas. In: Jaffe ES, ed. Surgical pathology of the lymph nodes and related organs, 2nd ed. Philadelphia: WB Saunders, 1995:344-89 (Major problems in pathology, vol. 16).
16. Jaffe ES. Post-thymic cell lymphomas. In: Jaffe ES, ed. Surgical pathology of the lymph nodes and related organs, 2nd ed. Philadelphia: WB Saunders, 1995:344-89 (Major problems in pathology, vol. 16).
17. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal T/NK cell lymphomas: definition, differential diagnosis, and epidemiology. Am J Surg Pathol, in press.
18. Kaiser U, Jaques G, Havemann K. Serum NCAM: a potential new prognostic marker for multiple myeloma [Letter] Blood 1994;83:871-3.
19. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688-95.
20. Kaplan J, Ravindranath Y, Inoue S. T-cell acute lymphoblastic leukemia with natural killer cell phenotype. Am J Hematol 1986;22:355-64.
21. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992;79:2432-7.
22. Kern WF, Spier CM, Miller TP, Grogan TM. NCAM (CD56) positive malignant lymphoma. Leuk Lymphoma 1993;12:1-10.
23. Kitty Moolenaar CEC, Muller EJ, Schol DJ, et al. Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res 1990;50:1102-6.
24. Komminoth P, Roth J, Saremaslani P, Matias-Guiu X, Wolfe HJ, Heitz PU. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia, an immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol 1994;18:399-411.
25. Lanier LL, Phillips JH, Kackett J, Tutt M, Kumar V. Natural killer cells: definition of a cell type rather than a function. J Immunol 1986;137:2735-9.
26. Mechtersheimer G. Towards the phenotyping of soft tissue tumors by cell surface molecules. Virchows Arch [A] 1991; 419:7-28.
27. Medeiros LJ, Jaffe ES, Chen YY, Weiss LM. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol 1992;16:439-47.
28. Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol 1991;22:1150-7.
29. Miller K, Auld J, Jessup E, Rhodes A, Ashton-Key M. Antigen unmasking in formalin-fixed routinely processed paraffin wax-embedded sections by pressure cooking: a comparison with microwave oven heating and traditional methods. Adv Anat Pathol 1995;2:60-4.
30. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM) positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284-96.
31. Nakamura S, Suchi T, Koshikawa T, et al. Aggressive rectal lymphoma of large granular lymphocytes with the histologie features of an angiocentric growth pattern. Cancer 1993;71: 249-56.
32. Ng CS, Chan JKC, Hui PK, Chan WC, Lo STH. Application of a T-cell receptor antibody βF1 for immunophenotypic analysis of malignant lymphomas. Am J Pathol 1988;132: 365-71.
33. Ng CS, Chan JKC, Lo STH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987; 18:1257-62.
34. Ng CS, Leung WT, Shiu W, et al. Test and teach. Number 60. Parts 1 and 2. Pathology 1989;21:88-9, 150-1.
35. Nichols GE, Normansell DE, Williams ME. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma. Mod Pathol 1994;7:819-24.
36. Schubert J, Lanier LL, Schmidt RE. Cluster report: CD56. In: Knapp W, Dorken B, Gilks WR, et al. eds. Leucocyte typing IV: white cell differentiation antigen. Oxford: Oxford University Press, 1989:699-702.
37. Scott AA, Kopecky KJ, Grogan TM. CD56: a determinant of extramedullary and central nervous system involvement in acute myeloid leukemia [Abstract]. Mod Pathol 1994;7: 120A.
38. Sun T, Brody J, Susin M, et al. Aggressive natural killer cell lymphoma/leukemia, a recently recognized clinicopathologic entity. Am J Surg Pathol 1993;17:1289-99.
39. Tome Y, Hirohashi S, Noguchi M, Shimosato Y. Preservation of cluster 1 small cell lung cancer antigen in zinc-formalin fixative and its application to immunohistological diagnosis. Histopathology 1990;16:469-74.
40. Tsang WYW, Chan JKC, Yip TTC, et al. In-situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Hum Pathol 1994;25:758-65.
41. van Camp B, Durie BGM, Spier C, et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH1; Leu19). Blood 1990;76:377-82.
42. van Gorp J, Liu WP, Jacobse K, et al. Epstein-Barr virus in nasal T-cell Iymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol 1994;173: 81-7.
43. Weiss LM, Gaffey MJ, Chen YY, Frierson HF. Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyer's ring non-Hodgkin's Iymphomas. Am J Surg Pathol 1992;16:156-62.
44. Wong KF, Chan JKC, Ng CS. CD56 (NCAM) positive malignant lymphoma. Leukemia Lymphoma 1994;14:29-36.
45. Wong KF, Chan JKC, Ng CS, Lee KC, Tsang WYW, Cheung MMC. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules and angiocentricity. Hum Pathol 1992;23:798-804.